1
|
Omisore AD, Odedeyi AA, Famurewa OC, Olasehinde O, Olugbade OT, Esan OT, Aderibigbe AS, Akinola RA. Practice, Perceptions, and Prospects of Mammography Screening in Nigeria: Insights from a National Survey of Female Health Workers. Clin Breast Cancer 2022; 22:462-472. [DOI: 10.1016/j.clbc.2022.02.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2021] [Revised: 02/03/2022] [Accepted: 02/14/2022] [Indexed: 11/17/2022]
|
2
|
Olasehinde O, Alatise O, Omisore A, Wuraola F, Odujoko O, Romanoff A, Akinkuolie A, Arowolo O, Adisa A, Knapp G, Famurewa O, Omisile I, Onabanjo E, Constable J, Omoniyi-Esan G, Adesunkanmi AR, Lawal O, Kingham TP. Contemporary management of breast cancer in Nigeria: Insights from an institutional database. Int J Cancer 2021; 148:2906-2914. [PMID: 33506499 DOI: 10.1002/ijc.33484] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2020] [Revised: 12/01/2020] [Accepted: 01/04/2021] [Indexed: 01/07/2023]
Abstract
High-quality data are needed to guide interventions aimed at improving breast cancer outcomes in sub-Saharan Africa. We present data from an institutional breast cancer database to create a framework for cancer policy and development in Nigeria. An institutional database was queried for consecutive patients diagnosed with breast cancer between January 2010 and December 2018. Sociodemographic, diagnostic, histopathologic, treatment and outcome variables were analyzed. Of 607 patients, there were 597 females with a mean age of 49.8 ± 12.2 years. Most patients presented with a palpable mass (97%) and advanced disease (80.2% ≥ Stage III). Immunohistochemistry was performed on 21.6% (131/607) of specimens. Forty percent were estrogen receptor positive, 32.8% were positive for HER-2 and 43.5% were triple negative. Surgery was performed on 49.9% (303/607) of patients, while 72% received chemotherapy and 7.9% had radiotherapy. At a median follow-up period of 20.5 months, the overall survival was 43.6% (95% CI -37.7 to 49.5). Among patients with resectable disease, 18.8% (57/303) experienced a recurrence. Survival was significantly better for early-stage disease (I and II) compared to late-stage disease (III or IV) (78.6% vs 33.3%, P < .001). Receipt of adjuvant radiotherapy after systemic chemotherapy was associated with improved survival in patients with locally advanced disease (68.5%, CI -46.3 to 86 vs 51%, CI 38.6 to 61.9, P < .001). This large cohort highlights the dual burden of advanced disease and inadequate access to comprehensive breast cancer care in Nigeria. There is a significant potential for improving outcomes by promoting early diagnosis and facilitating access to multimodality treatment.
Collapse
Affiliation(s)
- Olalekan Olasehinde
- Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria
| | - Olusegun Alatise
- Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria
| | - Adeleye Omisore
- Department of Radiology, Obafemi Awolowo University/ Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria
| | - Funmilola Wuraola
- Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria
| | - Oluwole Odujoko
- Department of Morbid Anatomy and Forensic pathology, Obafemi Awolowo University / Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria
| | - Anya Romanoff
- Breast Surgery, Dubin Breast Center, Icahn School of Medicine at The Mount Sinai Hospital, New York, New York, USA.,Department of Health System Design and Global Health, Icahn School of Medicine at The Mount Sinai Hospital, New York, New York, USA
| | - Akinbolaji Akinkuolie
- Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria
| | - Olukayode Arowolo
- Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria
| | - Adewale Adisa
- Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria
| | - Gregory Knapp
- Department of Oncology, Division of Surgical Oncology, University of Calgary, Alberta, Canada
| | - Olusola Famurewa
- Department of Radiology, Obafemi Awolowo University/ Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria
| | - Idowu Omisile
- Department of Psychology, Faculty of Social Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria
| | | | - Jeremy Constable
- Department of Surgery, Memorial Sloan-Kettering Cancer center, New York
| | - Ganiyat Omoniyi-Esan
- Department of Morbid Anatomy and Forensic pathology, Obafemi Awolowo University / Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria
| | - Abdul-Rasheed Adesunkanmi
- Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria
| | - Oladejo Lawal
- Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria
| | - Thomas P Kingham
- Department of Surgery, Memorial Sloan-Kettering Cancer center, New York
| |
Collapse
|